Flexible dose fesoterodine in the treatment of overactive bladder (OAB) (vol 112, pg 281, 2013)

被引：0
|
作者：
Tubaro, A.
De Nunzio, C.
机构：
来源：
BJU INTERNATIONAL | 2013年 / 112卷 / 06期
关键词：
D O I：
10.1111/bju.12430
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E430 / E430
页数：1
相关论文
共 50 条
  • [11] Imidafenacin for the treatment of overactive bladder (vol 14, pg 1383, 2013)
    Maggiore, Umberto Leone Roberti
    Scala, C.
    Venturini, P. L.
    Ferrero, S.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 301 - 301
  • [12] Effects of drug cessation after flexible-dose fesoterodine in patients with overactive bladder
    Khullar, Vik
    Cardozo, Linda
    Kelleher, Con J.
    Hall, Timothy
    Ryan, John
    Bitoun, Caty Ebel
    Darekar, Amanda
    Arumi, Daniel
    Wagg, Adrian
    [J]. BJU INTERNATIONAL, 2013, 112 (06) : 820 - 829
  • [13] REAL LIFE MANAGEMENT OF FLEXIBLE DOSE TREATMENTS WITH FESOTERODINE AND SOLIFENACIN FOR OVERACTIVE BLADDER PATIENTS
    Arumi, D.
    Sanchez-Ballester, F.
    Garcia-Mediero, J. M.
    Sanchez, M.
    Lizarraga, I
    [J]. NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S411 - S412
  • [14] Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study
    Wyndaele, J. -J.
    Goldfischer, E. R.
    Morrow, J. D.
    Gong, J.
    Tseng, L. -J.
    Guan, Z.
    Choo, M. -S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 560 - 567
  • [15] Fesoterodine dose response in subjects with overactive bladder syndrome
    Khullar, Vik
    Rovner, Eric S.
    Dmochowski, Roger
    Nitti, Victor
    Wang, Joseph
    Guan, Zhonghong
    [J]. UROLOGY, 2008, 71 (05) : 839 - 843
  • [16] Evaluation of fesoterodine fumarate for the treatment of an overactive bladder
    Mock, Stephen
    Dmochowski, Roger R.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1659 - 1666
  • [17] Comparison of solifenacin and fesoterodine in treatment of overactive bladder
    Ercan, Onder
    Kostu, Bulent
    Bakacak, Murat
    Aytac-Tohma, Yusuf
    Coskun, Bora
    Avci, Fazil
    Efe, Erkan
    [J]. SAUDI MEDICAL JOURNAL, 2015, 36 (10) : 1181 - 1185
  • [18] Development and Validation of the Chinese Overactive Bladder Symptom Score for Assessing Overactive Bladder Syndrome in a RESORT Study (vol 112, pg 276, 2013)
    Hung, Man-Jung
    Chou, Chieh-Lung
    Yen, Ta-Wei
    Chuang, Yao-Chi
    Meng, En
    Huang, Shih-Tsung
    Kuo, Hann-Chorng
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (06) : 367 - 367
  • [19] Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB)
    El-Zawahry, Ahmed
    [J]. CURRENT UROLOGY REPORTS, 2019, 20 (06)
  • [20] Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder (vol 75, pg 62, 2010)
    Dmochowski, R. R.
    Peters, K. M.
    Morrow, J. D.
    Guan, Z.
    Gong, J.
    Sun, F.
    [J]. UROLOGY, 2010, 75 (06) : 1519 - 1519
12345